NCT03409159Recruiting
Austrian Left Atrial Appendage Closure Registry
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 24 Nov 2017
- Start date
- 16 May 2017
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Medical University of Graz
- Diseases
- Atrial fibrillation
- NCT number
- NCT03409159
What you commit to
- Study type: Observational
- Planned participants: 200
- From 16 May 2017 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Absence of informed consent
Who the study is looking for
- Patients who received LAAC in Austria
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Graz Coordinator of this site? Confirm its status | Graz | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.